EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Loureirin analogues with colorectal cancer suppressive activity via regulating cell cycle and Fas death receptor

Peng Li, Xiangjuan Tian, Die Zhang, Huiping Ou, Qiufeng Huang, Wenbin Jin, Ran Liu

BMC Pharmacology and Toxicology · 2024

DOI: 10.1186/s40360-024-00758-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Pharmacology and Toxicology, 2024. Verfasst von Peng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Drug, Shenzhen Polytechnic University, 7098 Liuxian Avenue, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Chalcones, Antineoplastic Agents, fas Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chalcones and dihydrochalcones (DHCs) are important bioactive natural products (BNPs) isolated from traditional Chinese medicine. In this study, 13 chalcones were designed with the inspiration of Loureirin, a DHC extracted from Resina Draconis , and synthesized by classical Claisen-Schmidt reactions. Afterwards the reduction reactions were carried out to obtain the corresponding DHCs. Cytotoxicity assay indicated chalcones and DHCs possessed selective cytotoxicity against colorectal cancer (CRC) cells. The preliminary structure-activity relationships (SAR) of these compounds suggested the α, β -unsaturated ketone of the chalcones were crucial for the anticancer activity. Interestingly, compounds 3d and 4c exhibited selective anticancer activity against CRC cell line HCT116 with IC 50s of 8.4 and 17.9 μM but not normal cell. Moreover, 4c could also inhibit the migration and invasion of CRC cells. Mechanism investigations showed 4c could induce cell cycle G2/M arrest by regulating cell cycle-associated proteins and could also up-regulate Fas cell surface death receptor. The virtual docking further pointed out that compounds 3d and 4c could nicely bind to the Fas/FADD death domain complex (ID: 3EZQ). Furthermore, silencing of Fas significantly enhanced the proliferation of CRC cells and attenuated the cytotoxicity induced by 4c . These results suggested 4c exerted its anticancer activity possibly regulating cell cycle and Fas death receptor. In summary, this study investigated the anticancer activity and mechanism of Loureirin analogues in CRC, suggesting these compounds may warrant further investigation as promising anticancer drug candidates for the treatment of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsChalconesAntineoplastic Agentsfas ReceptorHumansStructure-Activity RelationshipHCT116 CellsMolecular Docking SimulationCell MovementCell CycleCell Line, Tumor

Stichwörter der Autor:innen

Cell cycle G2/M arrestChalcones and dihydrochalconesColorectal cancer (CRC)FasLoureirin analogues

Substanzen

ChalconesAntineoplastic Agentsfas Receptor

Autor:innen und Institutionen

  • School of Food and Drug, Shenzhen Polytechnic University, 7098 Liuxian Avenue, Shenzhen, 518055, China.
  • Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan and Faculty of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, China.
  • Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan and Faculty of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, China. 14900326…
  • School of Food and Drug, Shenzhen Polytechnic University, 7098 Liuxian Avenue, Shenzhen, 518055, China. liuran8515@outlook.com.

Zitieren

APA

Li, P., Tian, X., Zhang, D., Ou, H., Huang, Q., Jin, W., & Liu, R. (2024). Discovery of Loureirin analogues with colorectal cancer suppressive activity via regulating cell cycle and Fas death receptor. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-024-00758-2

Vancouver

Li P, Tian X, Zhang D, Ou H, Huang Q, Jin W, et al. Discovery of Loureirin analogues with colorectal cancer suppressive activity via regulating cell cycle and Fas death receptor. BMC Pharmacology and Toxicology. 2024. doi:10.1186/s40360-024-00758-2

BibTeX
@article{Li2024,
  author = {Li, Peng and Tian, Xiangjuan and Zhang, Die and Ou, Huiping and Huang, Qiufeng and Jin, Wenbin and Liu, Ran},
  title = {Discovery of Loureirin analogues with colorectal cancer suppressive activity via regulating cell cycle and Fas death receptor},
  journal = {BMC Pharmacology and Toxicology},
  year = {2024},
  doi = {10.1186/s40360-024-00758-2}
}
Kostenlos starten →